I reworded... BooDog Friday, 09/15/17 09:10:48 AM

New Post Public Reply Private Reply Replies (0) Message Board
BooDog
341
I reworded...
BooDog Friday, 09/15/17 09:10:48 AM
Re: scottsmith post# 196931
Post # of 196966

It is more of an incomplete thought. IMO Leo shouldn't have written what he did at all. It's more like fake news and it's very misleading. Certainly shouldn't be a sticky post. I'm not saying it's not legit, but clearly incomplete. To me it sounds like the Prurisol trial is going well and they don't want to compromise it by releasing too much data. Doesn't say we won't see any data. And until we see a press release about the issue, IT IS A NON ISSUE. IMO




Quote:
Quote:
From Leo:
Our plan was to to do an interim analysis of patients who completed week 6 and look for a signal. Recruitment into the study was slower than anticipated. At this time, as most patients have completed the study, a look could create investigator bias. It will likely effect the Alpha and require more patients to be added to the study.

I do appreciate your suggestions but it is very complicated.



If it's really that complicated they should take the time to figure out what they're going to do and let everyone know.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

IQVentures Acquires Aaron's Company for $504 Million Deal

Updated Category News Views 131

IQVentures Acquires Aaron's Company The acquisition landscape recently shifted with IQVentures Holdings, LLC, completing its purchase of Aaron's Company, Inc. (NYSE: AAN) in a landmark deal valued at approximately $504 million. This significant move culminates in a price of $10.10 per share, leading to the cessation of trading for Aaron's common stock on major exchanges....

Continue Reading
Vistra Increases Dividend for Common and Preferred Stockholders

Updated Category News Views 145

Vistra Boosts Shareholder Returns with Increased Dividends Vistra, a prominent player in the power generation and retail electricity sectors, has made headlines with its recent announcement regarding dividends. The company's board of directors has declared a quarterly dividend of $0.2260 per share for common stock holdings, amounting to a substantial total payout of...

Continue Reading
Hyperscale Data's Bitcoin Treasury Strategy Revealed

Updated Category News Views 126

Hyperscale Data's Bitcoin Treasury Update Hyperscale Data, Inc. (NYSE American: GPUS), known for its innovative approaches to artificial intelligence and digital asset management, has reached a notable milestone. The company recently reported holding approximately 545.4218 Bitcoin, which is a significant increase compared to their previous estimates. This treasury is part...

Continue Reading
Clarivate's Third Quarter Financial Performance and Future Outlook

Updated Category News Views 154

Overview of Clarivate's Q3 Financial Results Clarivate Plc (NYSE: CLVT), a noted global provider of transformative intelligence, has shared its financial results for the third quarter of the fiscal year. The company has seen continued acceleration in organic annual contract value (ACV) during this period. Significant Financial Highlights In this quarter, Clarivate's total...

Continue Reading
NexGold Advances with Industrial Approval for Goldboro Project

Updated Category News Views 180

NexGold Celebrates a Key Milestone in Project Development NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF), a dedicated gold-focused mining company, has recently reached an important milestone by securing Industrial Approval (IA) for the Goldboro Gold Project. This approval comes from the Government of Nova Scotia and represents one of the final provincial permits needed...

Continue Reading